定向增发能够提高研发支出水平吗 |
| |
引用本文: | 叶志强,崔惠贤,蔡旺春.定向增发能够提高研发支出水平吗[J].科技进步与对策,2018,35(22):101-106. |
| |
作者姓名: | 叶志强 崔惠贤 蔡旺春 |
| |
作者单位: | 1.华东理工大学 商学院,上海200237;2.中国药科大学 国际医药商学院,江苏 南京211198 |
| |
基金项目: | 国家自然科学基金项目(71371073) |
| |
摘 要: | 选择2006-2016年我国上市公司定向增发样本数据,采用系统GMM和OLS回归方法,实证检验定向增发募集资金对研发支出的影响。结果表明:定向增发不仅降低当期研发支出水平,而且降低累计研发支出水平;不同频次的定向增发均会降低研发支出水平。最后,以大股东及其关联方为定向增发对象,仍然部分支持定向增发会降低研发支出水平的结论,为股权融资背景下提高上市公司研发支出水平的论点提供了新证据,同时也可为提高上市公司研发支出水平的制度改革提供参考。
|
关 键 词: | 股权融资 定向增发 研发支出 消极投资者 利益侵占 |
Does Private Placement Increase R&D Expenditure? |
| |
Abstract: | This paper uses the Chinese listed firm data between 2006 and 2016 to empirically test the impact of private placement on R&D expenditure by system GMM and OLS methods. The results in the paper show that private placement declines not only current R&D expenditure, but also cumulative R&D expenditure, and different frequent private placements also decline R&D expenditure. At last, lager shareholders and their related parties as object of private placement to further be examined, but here partial evidences to still support the conclusions that private placements also decline R&D expenditure. These conclusions provide new evidence for improving R&D expenditure under the background of equity financing, and references for institutional reform to increase R&D expenditure in Chinese listed companies. |
| |
Keywords: | Equity Financing Private Placement R&D Expenditure Negative Investors Tunneling |
本文献已被 CNKI 等数据库收录! |
| 点击此处可从《科技进步与对策》浏览原始摘要信息 |
| 点击此处可从《科技进步与对策》下载免费的PDF全文 |